<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/itemcontent.css" type="text/css" media="screen"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
	<title>Oral Cancer News</title>
	
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<pubDate>Tue, 18 Nov 2008 10:43:52 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6</generator>
	<language>en</language>
			<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/oralcancernews/KsIl" type="application/rss+xml" /><item>
		<title>Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/457051665/</link>
		<comments>http://oralcancernews.org/wp/2008/11/analysis-of-prognostic-factors-in-patients-with-oropharyngeal-squamous-cell-carcinoma-treated-with-radiotherapy-alone-or-in-combination-with-systemic-chemotherapy/#comments</comments>
		<pubDate>Tue, 18 Nov 2008 10:43:52 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[chemotherapy]]></category>

		<category><![CDATA[radiotherapy]]></category>

		<category><![CDATA[retrospective study]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=743</guid>
		<description><![CDATA[Source: Arch Otolaryngol Head Neck Surg. 2008;134(11):1196-1204
Authors: Paola A. G. Pedruzzi, MD et al.
Objective:
To assess the prognostic significance of several factors in oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with chemotherapy.
Design:
Retrospective study.
Setting:
Erasto Gaertner Hospital, Curitiba, Brazil, and A. C. Camargo Hospital, São Paulo, Brazil.
Patients:
A total of 361 patients treated for squamous [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/analysis-of-prognostic-factors-in-patients-with-oropharyngeal-squamous-cell-carcinoma-treated-with-radiotherapy-alone-or-in-combination-with-systemic-chemotherapy/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/analysis-of-prognostic-factors-in-patients-with-oropharyngeal-squamous-cell-carcinoma-treated-with-radiotherapy-alone-or-in-combination-with-systemic-chemotherapy/</feedburner:origLink></item>
		<item>
		<title>7 Facts you need to know about HPV and Gardasil</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/457051666/</link>
		<comments>http://oralcancernews.org/wp/2008/11/7-facts-you-need-to-know-about-hpv-and-gardasil/#comments</comments>
		<pubDate>Tue, 18 Nov 2008 10:34:59 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[Gardasil]]></category>

		<category><![CDATA[HPV]]></category>

		<category><![CDATA[infection]]></category>

		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=740</guid>
		<description><![CDATA[Source: www.usnews.com
Author: Bernadine Healy M.D.
As women—and soon men—gain access to the new Merck vaccine Gardasil, which targets the sexually transmitted human papillomavirus, the Centers for Disease Control and Prevention has stepped up efforts to identify the 25,000 or more cancers primarily associated with HPV that increase the burden of cancer in the United States each [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/7-facts-you-need-to-know-about-hpv-and-gardasil/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/7-facts-you-need-to-know-about-hpv-and-gardasil/</feedburner:origLink></item>
		<item>
		<title>LSUHSC Public Health contributes to estimate of HPV-related cancers</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/455140011/</link>
		<comments>http://oralcancernews.org/wp/2008/11/lsuhsc-public-health-contributes-to-estimate-of-hpv-related-cancers/#comments</comments>
		<pubDate>Sun, 16 Nov 2008 18:40:36 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[black-white disparity]]></category>

		<category><![CDATA[HPV]]></category>

		<category><![CDATA[human papillomavirus]]></category>

		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=736</guid>
		<description><![CDATA[Source: www.canceraids.org
Author: staff
Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date. [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/lsuhsc-public-health-contributes-to-estimate-of-hpv-related-cancers/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/lsuhsc-public-health-contributes-to-estimate-of-hpv-related-cancers/</feedburner:origLink></item>
		<item>
		<title>High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/455129768/</link>
		<comments>http://oralcancernews.org/wp/2008/11/high-rate-of-severe-radiation-dermatitis-during-radiation-therapy-with-concurrent-cetuximab-in-head-and-neck-cancer-results-of-a-survey-in-eortc-institutes/#comments</comments>
		<pubDate>Sun, 16 Nov 2008 18:29:22 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[cetuximab]]></category>

		<category><![CDATA[EORTC]]></category>

		<category><![CDATA[radiation dermatitis]]></category>

		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=732</guid>
		<description><![CDATA[Source: Radiother Oncol, October 30, 2008
Author: Christian Giro et al.
Objective:
Examination of the rate of grade III or grade IV radiation dermatitis during treatment of head and neck cancer (HNC) with radiotherapy (RT) and concurrent cetuximab in EORTC centres.
Materials and Method:
A questionnaire was sent to all members of the EORTC Radiation Oncology Group and Head and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/high-rate-of-severe-radiation-dermatitis-during-radiation-therapy-with-concurrent-cetuximab-in-head-and-neck-cancer-results-of-a-survey-in-eortc-institutes/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/high-rate-of-severe-radiation-dermatitis-during-radiation-therapy-with-concurrent-cetuximab-in-head-and-neck-cancer-results-of-a-survey-in-eortc-institutes/</feedburner:origLink></item>
		<item>
		<title>Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/455121824/</link>
		<comments>http://oralcancernews.org/wp/2008/11/re-irradiation-with-concurrent-chemotherapy-in-recurrent-head-and-neck-cancer-a-decision-analysis-model-based-on-a-systematic-review/#comments</comments>
		<pubDate>Sun, 16 Nov 2008 18:17:31 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[concurrent chemotherapy]]></category>

		<category><![CDATA[radiation]]></category>

		<category><![CDATA[re-irradiation]]></category>

		<category><![CDATA[recurrence]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=725</guid>
		<description><![CDATA[Source: Clin Otolaryngol, August 1, 2008; 33(4): 331-7
Authors: V Paleri and CG Kelly
Objectives:
Local recurrence is the major cause of treatment failure in head and neck cancer patients after radiation or combined therapy. If surgically unresectable, management involves supportive care or chemotherapy with palliative intent. Recent studies have assessed the role of re-irradiating these patients with [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/re-irradiation-with-concurrent-chemotherapy-in-recurrent-head-and-neck-cancer-a-decision-analysis-model-based-on-a-systematic-review/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/re-irradiation-with-concurrent-chemotherapy-in-recurrent-head-and-neck-cancer-a-decision-analysis-model-based-on-a-systematic-review/</feedburner:origLink></item>
		<item>
		<title>Doctors warn of HPV link to developing oral cancer</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/454963277/</link>
		<comments>http://oralcancernews.org/wp/2008/11/doctors-warn-of-hpv-link-to-developing-oral-cancer/#comments</comments>
		<pubDate>Sun, 16 Nov 2008 15:03:40 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[HPV]]></category>

		<category><![CDATA[human papillomavirus]]></category>

		<category><![CDATA[oral sex]]></category>

		<category><![CDATA[tonsils]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=722</guid>
		<description><![CDATA[Source: Tampa Bay Online (www2.tbo.com)
Author: staff
Ten years ago, most of Brian Nussenbaum&#8217;s oral cancer patients were men older than 60 who used tobacco and drank heavily.
Today, his patients look different, as does the risky behavior that seems to be leading to their cancer.
Nussenbaum, an ear, nose and throat doctor at Washington University in St. Louis, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/doctors-warn-of-hpv-link-to-developing-oral-cancer/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/doctors-warn-of-hpv-link-to-developing-oral-cancer/</feedburner:origLink></item>
		<item>
		<title>Sweetest word for a mother to hear</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/454948293/</link>
		<comments>http://oralcancernews.org/wp/2008/11/sweetest-word-for-a-mother-to-hear/#comments</comments>
		<pubDate>Sun, 16 Nov 2008 14:46:00 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[early detection]]></category>

		<category><![CDATA[surgery]]></category>

		<category><![CDATA[tongue]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=718</guid>
		<description><![CDATA[Source: www.journallive.co.uk
Author: Neil MacKay
It is a memorable moment in any mother’s life when her child utters their first word. But when Daniel Sewell said “Mam” for the first time it was an extra special for his mum Alison.
For Daniel was given a “new” tongue during pioneering surgery for mouth cancer at Newcastle’s Royal Victoria Infirmary [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/sweetest-word-for-a-mother-to-hear/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/sweetest-word-for-a-mother-to-hear/</feedburner:origLink></item>
		<item>
		<title>Adult smoking is at record low</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/454235556/</link>
		<comments>http://oralcancernews.org/wp/2008/11/adult-smoking-is-at-record-low/#comments</comments>
		<pubDate>Sat, 15 Nov 2008 19:43:05 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[CDC]]></category>

		<category><![CDATA[quit]]></category>

		<category><![CDATA[smokeless]]></category>

		<category><![CDATA[smoking]]></category>

		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=714</guid>
		<description><![CDATA[Source: www2.journalnow.com
Author: Richard Craver
A rate below 20 percent has more symbolic than commercial significance, tobacco analyst says Smoking among U.S. adults hit a record low during 2007, with less than one in five lighting up.
Although breaking through the 20 percent threshold was applauded by anti-smoking groups last week, they acknowledged that an ambitious goal of [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/adult-smoking-is-at-record-low/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/adult-smoking-is-at-record-low/</feedburner:origLink></item>
		<item>
		<title>Dietary factors and oral and pharyngeal cancer risk</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/454131600/</link>
		<comments>http://oralcancernews.org/wp/2008/11/dietary-factors-and-oral-and-pharyngeal-cancer-risk/#comments</comments>
		<pubDate>Sat, 15 Nov 2008 16:58:35 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[alcohol]]></category>

		<category><![CDATA[diet]]></category>

		<category><![CDATA[fruit]]></category>

		<category><![CDATA[tobacco]]></category>

		<category><![CDATA[vegetables]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=712</guid>
		<description><![CDATA[Source: Oral Oncol, November 4, 2
Authors: Ersilia Lucenteforte et al 
We reviewed data from six cohort studies and approximately 40 case-control studies on the relation between selected aspects of diet and the risk of oral and pharyngeal cancer. Fruit and vegetables were inversely related to the risk: the pooled relative risk (RR) for high vegetable [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/dietary-factors-and-oral-and-pharyngeal-cancer-risk/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/dietary-factors-and-oral-and-pharyngeal-cancer-risk/</feedburner:origLink></item>
		<item>
		<title>HPV virus helps cervical and head and neck cancers resist treatment and grow and spread</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/454126786/</link>
		<comments>http://oralcancernews.org/wp/2008/11/hpv-virus-helps-cervical-and-head-and-neck-cancers-resist-treatment-and-grow-and-spread/#comments</comments>
		<pubDate>Sat, 15 Nov 2008 16:51:58 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[HPV]]></category>

		<category><![CDATA[human papillomavirus]]></category>

		<category><![CDATA[signaling pathway]]></category>

		<category><![CDATA[virus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=709</guid>
		<description><![CDATA[Source: www.sciencedaily.com
Author: staff
The human papillomavirus (HPV) allows infected cervical and head and neck cancer cells to maintain internal molecular conditions that make the cancers resistant to therapy and more likely to grow and spread, resulting in a poor prognosis for patients, researchers with UCLA&#8217;s Jonsson Cancer Center found.
Virtually all human cancers experience a state called [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/hpv-virus-helps-cervical-and-head-and-neck-cancers-resist-treatment-and-grow-and-spread/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/hpv-virus-helps-cervical-and-head-and-neck-cancers-resist-treatment-and-grow-and-spread/</feedburner:origLink></item>
		<item>
		<title>Noted Hopkins scientist says research indicates need for effective HPV vaccine for women and men and a simple HPV screening test</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/453154326/</link>
		<comments>http://oralcancernews.org/wp/2008/11/noted-hopkins-scientist-says-research-indicates-need-for-effective-hpv-vaccine-for-women-and-men-and-a-simple-hpv-screening-test/#comments</comments>
		<pubDate>Fri, 14 Nov 2008 17:23:26 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[OCF In The News]]></category>

		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[HPV]]></category>

		<category><![CDATA[human papillomavirus]]></category>

		<category><![CDATA[Maura Gillison]]></category>

		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=706</guid>
		<description><![CDATA[Source: healthhearsay.blogspot.com
Author: staff
A call to explore a broader use of HPV (human papillomavirus) vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by a Johns Hopkins Kimmel Cancer Center investigator.
Leading HPV expert Maura Gillison, M.D., Ph.D., the first to identify HPV infection as the cause [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/noted-hopkins-scientist-says-research-indicates-need-for-effective-hpv-vaccine-for-women-and-men-and-a-simple-hpv-screening-test/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/noted-hopkins-scientist-says-research-indicates-need-for-effective-hpv-vaccine-for-women-and-men-and-a-simple-hpv-screening-test/</feedburner:origLink></item>
		<item>
		<title>Bone healing after dental extractions in irradiated patients: a pilot study on a novel technique for volume assessment of healing tooth sockets.</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/452306578/</link>
		<comments>http://oralcancernews.org/wp/2008/11/bone-healing-after-dental-extractions-in-irradiated-patients-a-pilot-study-on-a-novel-technique-for-volume-assessment-of-healing-tooth-sockets/#comments</comments>
		<pubDate>Thu, 13 Nov 2008 23:12:21 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[CBCT]]></category>

		<category><![CDATA[cone beam CT scanning]]></category>

		<category><![CDATA[extraction]]></category>

		<category><![CDATA[teeth]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=703</guid>
		<description><![CDATA[Source: Clin Oral Investig, November 5, 2008
Author: Jimoh Olubanwo Agbaje et al.
The aim of this study was to evaluate longitudinally the bone-healing process by measuring volumetric changes of the extraction sockets in head and neck cancer patients undergoing radiotherapy after tooth extraction.
A total group of 15 patients (nine males, six females) undergoing tooth extraction at [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/bone-healing-after-dental-extractions-in-irradiated-patients-a-pilot-study-on-a-novel-technique-for-volume-assessment-of-healing-tooth-sockets/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/bone-healing-after-dental-extractions-in-irradiated-patients-a-pilot-study-on-a-novel-technique-for-volume-assessment-of-healing-tooth-sockets/</feedburner:origLink></item>
		<item>
		<title>Study suggests Merck’s Gardasil is effective in males</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/452306579/</link>
		<comments>http://oralcancernews.org/wp/2008/11/study-suggests-mercks-gardasil-is-effective-in-males/#comments</comments>
		<pubDate>Thu, 13 Nov 2008 23:09:00 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[Cervarix]]></category>

		<category><![CDATA[cervical cancer]]></category>

		<category><![CDATA[Gardasil]]></category>

		<category><![CDATA[HPV]]></category>

		<category><![CDATA[human papillomavirus HPV]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=700</guid>
		<description><![CDATA[Source: money.cnn.com
Author: Peter Loftus
 A new study suggests Merck &#038; Co.&#8217;s (MRK) Gardasil vaccine, which is primarily given to prevent cervical cancer in girls and women, may also be effective in preventing genital warts and penile cancer when given to males.
Merck hopes the company-funded study will support roughly doubling the target population for the vaccine, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/study-suggests-mercks-gardasil-is-effective-in-males/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/study-suggests-mercks-gardasil-is-effective-in-males/</feedburner:origLink></item>
		<item>
		<title>Does surgical resection of pulmonary metastases of head and neck cancer improve survival?</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/452290319/</link>
		<comments>http://oralcancernews.org/wp/2008/11/does-surgical-resection-of-pulmonary-metastases-of-head-and-neck-cancer-improve-survival/#comments</comments>
		<pubDate>Thu, 13 Nov 2008 23:05:15 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[Lymph node dissection]]></category>

		<category><![CDATA[Pulmonary metastases]]></category>

		<category><![CDATA[survival]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=695</guid>
		<description><![CDATA[Source: Annals of Surgical Oncology 15:2915-2926 (2008)
Author: Hauke Winter, MD et al.
Background:
The prognosis of patients with metastasized head and neck cancer is poor. Limited experience exists with the benefit of resection of lung metastases and systematic mediastinal and hilar lymph node dissection on survival of patients with head and neck carcinoma.
Methods:
Eighty patients undergoing metastasectomy for [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/does-surgical-resection-of-pulmonary-metastases-of-head-and-neck-cancer-improve-survival/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/does-surgical-resection-of-pulmonary-metastases-of-head-and-neck-cancer-improve-survival/</feedburner:origLink></item>
		<item>
		<title>World renowned HPV expert joins OSU cancer program</title>
		<link>http://feeds.feedburner.com/~r/oralcancernews/KsIl/~3/452287267/</link>
		<comments>http://oralcancernews.org/wp/2008/11/world-renowned-hpv-expert-joins-osu-cancer-program/#comments</comments>
		<pubDate>Thu, 13 Nov 2008 23:00:01 +0000</pubDate>
		<dc:creator>Sheldon</dc:creator>
		
		<category><![CDATA[OCF In The News]]></category>

		<category><![CDATA[Oral Cancer News]]></category>

		<category><![CDATA[HPV]]></category>

		<category><![CDATA[human papilloma virus]]></category>

		<category><![CDATA[Maura Gillison]]></category>

		<category><![CDATA[oral cancer foundation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=692</guid>
		<description><![CDATA[Source: media-newswire.com
Author: press release
Leading human papilloma virus ( HPV ) expert Maura Gillison, MD, PhD, will join The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute on Jan. 1 as a professor of medicine in the division of hematology and oncology and a member of the Cancer Control and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/2008/11/world-renowned-hpv-expert-joins-osu-cancer-program/feed/</wfw:commentRss>
		<feedburner:origLink>http://oralcancernews.org/wp/2008/11/world-renowned-hpv-expert-joins-osu-cancer-program/</feedburner:origLink></item>
	</channel>
</rss>
